Tool Calling and Plugins for Pharmacoeconomics and

Data Characteristics in This Category

Pharmacoeconomic data focuses on cost-benefit, cost-utility, and cost-effectiveness analyses of drugs. Data sources include clinical trial results, real-world evidence (RWE), health insurance reimbursement databases, medical service pricing catalogs, and patient surveys. This data typically exists in structured tables (e.g., Excel, CSV, database records) and unstructured text (e.g., clinical reports, literature reviews). Update frequencies vary; clinical trial data is released as research progresses, while health insurance catalogs and pricing information may be adjusted annually or semi-annually. Document structures are diverse. For example, cost data might include fields such as drug purchase price, administrative fees, and adverse event handling costs. Utility data might involve metrics like Quality-Adjusted Life Years (QALY) or Disability-Adjusted Life Years (DALY). Field names and units require strict differentiation.

Constraints Imposed by These Characteristics on "Tool Calling and Plugins"

The diversity and complexity of pharmacoeconomic data impose specific requirements on tool calling and plugins. First, data sources are extensive and formats vary, necessitating robust data parsing and preprocessing capabilities to unify data structures. For instance, reimbursement data from different health insurance databases may have differing drug codes and cost units, requiring plugins to perform standardization. Second, calculating specialized metrics like QALY and DALY requires tools to call specific statistical analysis libraries or external computation services. Third, varying data update frequencies mean tool calling needs to support scheduled tasks or incremental update mechanisms to ensure the timeliness of analysis results. Finally, identifying and associating adverse drug reactions in pharmacovigilance may require calling Natural Language Processing (NLP) tools to extract key information from unstructured text and integrate it with structured economic data for analysis.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxContext`	`4096`	Accommodates complex background information and detailed calculation processes found in pharmacoeconomic reports, ensuring the model understands the complete context.
`tool_timeout_seconds`	`120 seconds`	Accounts for potential time-consuming external statistical calculations or database queries, preventing critical analysis steps from being interrupted by timeouts.
`plugin_max_retries`	`3 times`	Addresses occasional network fluctuations or temporary failures of external services, improving the robustness of tool calls.
`function_call_strict_mode`	`true`	Ensures the model strictly adheres to defined tool function signatures during calls, preventing the generation of parameters that do not conform to expected formats, especially in financial or statistical calculations.
`prompt_template`	Contains `{{query}}` and `{{tools_schema}}`	Clearly instructs the model to understand the user query and then, referencing the provided tool function definitions, select appropriate tools for pharmacoeconomic analysis or data extraction.
`data_extraction_model_version`	`Qwen2-7B-Instruct-v0.1`	Selects a model version that performs well in structured information extraction, suitable for extracting adverse event information or cost data from clinical reports.

Common Pitfalls

Tool calls return HTTP 400 or 500 error codes. This occurs when parameters passed to external APIs are incorrectly formatted or essential fields are missing, such as drug codes not being uniformly converted as required by the API.
The model fails to autonomously select appropriate pharmacoeconomic analysis tools. This may be due to unclear tool function descriptions or a prompt_template that does not effectively guide the model to understand when to call specific analysis functions.
Adverse event information extracted from unstructured text is incomplete or inaccurate. This can happen if the data_extraction_model_version performs poorly when processing specific medical terminology or abbreviations, requiring fine-tuning or the use of a more specialized model.

Verification Steps

Submit queries containing typical pharmacoeconomic analysis requirements. Observe whether the model correctly identifies and calls relevant external computation tools, such as cost-benefit analysis modules.
Test different formats of pharmacovigilance data input. Verify if the toolchain can accurately parse and extract key information like adverse events, drug names, and dosages, and pass them to subsequent processing steps.
Examine tool call logs. Confirm that the tool_timeout_seconds setting is sufficient and that no call failures occurred due to slow external service responses.
Simulate scenarios where external tool services are temporarily unavailable. Verify if the plugin_max_retries configuration enables the system to perform reasonable retries and provide clear error messages upon ultimate failure.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.